Quality of life of weekly, dose-dense versus standard chemotherapy for ovarian cancer in the ICON8 study

類似資料

• Weekly platinum-based chemotherapy versus 3-weekly platinum-based chemotherapy for newly diagnosed ovarian cancer (ICON8): quality-of-life results of a phase 3, randomised, controlled trial
  著者:: Blagden, S, 等
  出版事項: (2020)
• Response to neoadjuvant chemotherapy in ICON8: A GCIG phase III randomised trial evaluating weekly dose-dense chemotherapy integration in first-line epithelial ovarian/fallopian tube/primary peritoneal carcinoma (EOC) treatment
  著者:: Clamp, A, 等
  出版事項: (2018)
• ICON8: A GCIG phase III randomised trial evaluating weekly dosedense chemotherapy integration in first- line epithelial ovarian/fallopian tube/primary peritoneal carcinoma (EOC) treatment: Results of primary progression- free survival (PFS) analysis
  著者:: Clamp, A, 等
  出版事項: (2017)
• Standard chemotherapy with or without bevacizumab for women with newly diagnosed ovarian cancer (ICON7): overall survival results of a phase 3 randomised trial
  著者:: Oza, A, 等
  出版事項: (2015)
• Is iconic memory iconic?
  著者:: Quilty-Dunn, J
  出版事項: (2019)